Akari Therapeutics
AKTX
13 hedge funds and large institutions have $644K invested in Akari Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
71% more capital invested
Capital invested by funds: $377K → $644K (+$267K)
44% more funds holding
Funds holding: 9 → 13 (+4)
0.04% more ownership
Funds ownership: 0% → 0.04% (+0.04%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$227K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$99.9K |
| 3 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$8.57K |
| 4 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$5.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFW
Omnia Family Wealth
Aventura,
Florida
|
-$31.5K |
| 2 |
Renaissance Technologies
New York
|
-$1.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $210K | +$227K | +4,495 | New |
|
|
PAI
2
Palo Alto Investors
Palo Alto,
California
| $171K | – | – | – |
|
|
3
HighTower Advisors
Chicago,
Illinois
| $92.7K | +$99.9K | +1,981 | New |
|
|
OFW
4
Omnia Family Wealth
Aventura,
Florida
| $73.3K | -$31.5K | -624 | -28% |
|
5
Cerity Partners
New York
| $27.7K | – | – | – |
|
|
CAM
6
Cresset Asset Management
Chicago,
Illinois
| $21.5K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $20.4K | -$1.26K | -25 | -5% |
|
|
ACM
8
Accent Capital Management
Centerville,
Ohio
| $11.7K | – | – | – |
|
|
NA
9
NewEdge Advisors
New Orleans,
Louisiana
| $7.96K | +$8.57K | +170 | New |
|
|
EWA
10
EverSource Wealth Advisors
Birmingham,
Alabama
| $5.12K | +$5.5K | +109 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $2.52K | +$2.72K | +54 | New |
|
12
Bank of America
Charlotte,
North Carolina
| $175 | – | – | – |
|
|
TC
13
Truvestments Capital
Sarasota,
Florida
| $59 | – | – | – |
|
|
CPG
14
Cornerstone Planning Group
Fairfield,
New Jersey
| $5 | – | – | – |
|
15
Morgan Stanley
New York
| $4 | – | – | – |
|
AKTX Hedge Fund Activity: Q2 2025 in Review
13 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q2 2025, worth a combined $644K — up 71% from $377K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AKTX positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $227K. The largest seller was Omnia Family Wealth, cutting an estimated $31.5K.
- 13 institutional investors held Akari Therapeutics (AKTX) as of Q2 2025, up from 9 in Q1 2025.
- Funds reported $644K of Akari Therapeutics stock for Q2 2025, up 71% quarter-over-quarter.
- 5 funds opened new Akari Therapeutics positions in Q2 2025 and 1 closed out, a net change of +4 holders.
- The largest Akari Therapeutics buyer in Q2 2025 was Sabby Management, an estimated $227K added.
- The largest Akari Therapeutics seller in Q2 2025 was Omnia Family Wealth, an estimated $31.5K sold.
Based on aggregated 13F filings for Q2 2025.